Repare Therapeutics Inc.
RPTX
$1.78
-$0.06-3.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 109.47M | 124.23M | 152.79M | 179.43M | 208.12M |
| Total Receivables | 14.62M | 11.57M | 12.35M | 14.23M | 14.64M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.48M | 4.55M | 6.01M | 6.74M | 5.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 126.57M | 140.34M | 171.15M | 200.40M | 228.54M |
|
|
|||||
| Total Current Assets | 126.57M | 140.34M | 171.15M | 200.40M | 228.54M |
| Net Property, Plant & Equipment | 701.00K | 2.47M | 4.22M | 5.22M | 5.42M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.63M | 1.21M | 1.14M | 765.00K | 1.38M |
| Total Assets | 130.49M | 144.02M | 176.51M | 206.39M | 235.34M |
|
|
|||||
| Total Accounts Payable | 4.01M | 2.28M | 3.62M | 10.66M | 7.18M |
| Total Accrued Expenses | 11.87M | 14.77M | 19.65M | 17.68M | 21.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 649.00K | 1.37M | 1.85M | 2.22M | 1.96M |
| Total Finance Division Other Current Liabilities | 3.56M | 500.00K | 166.00K | 530.00K | 335.00K |
| Total Other Current Liabilities | 3.56M | 500.00K | 166.00K | 530.00K | 335.00K |
| Total Current Liabilities | 20.09M | 18.93M | 25.29M | 31.08M | 31.45M |
|
|
|||||
| Total Current Liabilities | 20.09M | 18.93M | 25.29M | 31.08M | 31.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 88.00K | 346.00K | 218.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.09M | 18.93M | 25.38M | 31.43M | 31.67M |
|
|
|||||
| Common Stock & APIC | 574.96M | 572.90M | 568.87M | 563.95M | 558.53M |
| Retained Earnings | -464.59M | -447.84M | -417.80M | -389.13M | -354.72M |
| Treasury Stock & Other | 35.00K | 36.00K | 64.00K | 140.00K | -134.00K |
| Total Common Equity | 110.41M | 125.10M | 151.13M | 174.96M | 203.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 110.41M | 125.10M | 151.13M | 174.96M | 203.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 110.41M | 125.10M | 151.13M | 174.96M | 203.68M |
|
|
|||||